Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase NA 2Phase 1/2 2Phase 2/3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Myeloid 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 18Leukemia 17Lymphoma 13Myelodysplastic Syndromes 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 7Hodgkin Disease 7Blast Crisis 7Myeloproliferative Disorders 6Multiple Myeloma 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Congenital Abnormalities 6Polycythemia Vera 5Neoplasms, Plasma Cell 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Lymphocytic, Chronic, B-Cell 5Graft vs Host Disease 5Thrombocythemia, Essential 4Primary Myelofibrosis 4Pdgfra-Associated Chronic Eosinophilic Leukemia 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Neutrophilic, Chronic 4Hematologic Neoplasms 4Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 3Cytarabine 3fludarabine 2Tacrolimus 2Rituximab 2Oxaliplatin 2Methotrexate 2Clofarabine 2Busulfan 2Antilymphocyte Serum 2veltuzumab 1thymoglobulin 1pegfilgrastim 1ofatumumab 1merphos 1ethanolamine oleate 1dinaciclib 1carmustine, poliferprosan 20 drug combination 1acalabrutinib 1Whole-Body Irradiation 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Pentetic Acid 1Mycophenolic Acid 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia, Prolymphocytic × Busulfan × Clear all
NCT01629511 2020-02-24

Allogeneic Stem Cell Transplant for CLL

M.D. Anderson Cancer Center

Phase 1/2 Terminated
15 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

NCT00448357 2017-07-17

LCCC0510

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Completed
54 enrolled 17 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Sezary Syndrome, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡